The cost effectiveness of testing for onychomycosis versus empiric treatment of onychodystrophies with oral antifungal agents.
Mehregan
D R
DR
Wayne State University Department of Dermatology, Detroit, Michigan, USA.
Gee
S L
SL
D000284:Administration, Oral; D000935:Antifungal Agents / Q000008:administration & dosage*; D003362:Cost-Benefit Analysis; D003937:Diagnosis, Differential; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D009281:Naphthalenes / Q000627:therapeutic use; D014009:Onychomycosis / Q000175:diagnosis* / Q000188:drug therapy* / Q000191:economics; D000077291:Terbinafine
D000935:Antifungal Agents; D009281:Naphthalenes; D017964:Itraconazole; D000077291:Terbinafine